REQUEST A DEMO
Total
USD $0.00
Search more companies

Krka Magyarorszag Kft. (Hungary)

Main Activities: Other Management Consulting Services
Full name: KRKA Magyarorszag Kereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Krka is one of the leading generic pharmaceutical companies worldwide. Its high quality, effective and safe products cover most therapeutic areas and we complete successfully with against other companies in our sector. Our core business operations involve pharmaceuticals and chemicals. We at Krka focus mainly on developing our own high quality generic medicines with added value, which we market under our own brand names. Our core products are those for human use and include prescription pharmaceuticals and non-prescription products. We also manufacture and market animal health products.

Headquarters
Dunavirag utca 2-6. 3. torony. ep. 6. emelet
Budapest; Budapest; Postal Code: 1138

Contact Details: Purchase the Krka Magyarorszag Kft. report to view the information.

Website: http://www.krka.biz

Basic Information
Total Employees:
Purchase the Krka Magyarorszag Kft. report to view the information.
Outstanding Shares:
Purchase the Krka Magyarorszag Kft. report to view the information.
Registered Capital:
Purchase the Krka Magyarorszag Kft. report to view the information.
Financial Auditors:
Purchase the Krka Magyarorszag Kft. report to view the information.
Incorporation Date:
August 24, 1993
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Krka Magyarorszag Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.71%
Total operating revenue
4.41%
Operating profit (EBIT)
10.27%
EBITDA
7.08%
Net Profit (Loss) for the Period
5.67%
Total assets
10.13%
Total equity
15.3%
Operating Profit Margin (ROS)
0.2%
Net Profit Margin
0%
Return on Equity (ROE)
-1.21%
Quick Ratio
0.49%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?